Adoption of a Tetrahedral DNA Nanostructure as a Multifunctional Biomaterial for Drug Delivery
ACS Pharmacology & Translational Science · 09.08.2024 · 7 (8) · 2204-2214
DOI: 10.1021/acsptsci.4c00308 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 24.07.2024. Verfasst von Jiaqi Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, Ontario N6A 5B9, Canada. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian Institutes of Health Research, Western University, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
DNA nanostructures have been widely researched in recent years as emerging biomedical materials for drug delivery, biosensing, and cancer therapy, in addition to their hereditary function. Multiple precisely designed single-strand DNAs can be fabricated into complex, three-dimensional DNA nanostructures through a simple self-assembly process. Among all of the synthetic DNA nanostructures, tetrahedral DNA nanostructures (TDNs) stand out as the most promising biomedical nanomaterial. TDNs possess the merits of structural stability, cell membrane permeability, and natural biocompatibility due to their compact structures and DNA origin. In addition to their inherent advantages, TDNs were shown to have great potential in delivering therapeutic agents through multiple functional modifications. As a multifunctional material, TDNs have enabled innovative pharmaceutical applications, including antimicrobial therapy, anticancer treatment, immune modulation, and cartilage regeneration. Given the rapid development of TDNs in the biomedical field, it is critical to understand how to successfully produce and fine-tune the properties of TDNs for specific therapeutic needs and clinical translation. This article provides insights into the synthesis and functionalization of TDNs and summarizes the approaches for TDN-based therapeutics delivery as well as their broad applications in the field of pharmaceutics and nanomedicine, challenges, and future directions.
Autor:innen und Institutionen
- Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, Ontario N6A 5B9, Canada.
- Collaborative Specialization in Musculoskeletal Health Research and Bone and Joint Institute, The University of Western Ontario, London, Ontario N6A 5B9, Canada.
- School of Biomedical Engineering, The University of Western Ontario, London, Ontario N6A 5B9, Canada.
- Department of Chemistry, The University of Western Ontario, London, Ontario N6A 5B9, Canada.
ORCID-Profile: Jiaqi Huang, Arghya Paul
Förderung
- Canadian Institutes of Health Research
- Western University
- Natural Sciences and Engineering Research Council of Canada
- New Frontiers in Research Fund
- Province of Ontario
Zitieren
APA
Huang, J., Chakraborty, A., Tadepalli, L. S., & Paul, A. (2024). Adoption of a Tetrahedral DNA Nanostructure as a Multifunctional Biomaterial for Drug Delivery. ACS Pharmacology & Translational Science, 7(8), 2204-2214. https://doi.org/10.1021/acsptsci.4c00308
Vancouver
Huang J, Chakraborty A, Tadepalli LS, Paul A. Adoption of a Tetrahedral DNA Nanostructure as a Multifunctional Biomaterial for Drug Delivery. ACS Pharmacology & Translational Science. 2024;7(8):2204-2214. doi:10.1021/acsptsci.4c00308
BibTeX
@article{Huang2024,
author = {Huang, Jiaqi and Chakraborty, Aishik and Tadepalli, Lakshmi Suchitra and Paul, Arghya},
title = {Adoption of a Tetrahedral DNA Nanostructure as a Multifunctional Biomaterial for Drug Delivery},
journal = {ACS Pharmacology & Translational Science},
year = {2024},
volume = {7},
number = {8},
pages = {2204--2214},
doi = {10.1021/acsptsci.4c00308}
}
EUVIMED